Removing Barriers to Allergy Diagnostic Testing Act of 2019

Summary

Removing Barriers to Allergy Diagnostic Testing Act of 2019 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 1 April 2019

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

2. 1 April 2019

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

3. 1 April 2019

   Introduced

   Introduced in House

   Source: IntroReferral

4. 1 April 2019

   Introduced

   Introduced in House

   Source: IntroReferral

5. 2 April 2019

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 1 April 2019 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 1 April 2019

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 1 April 2019

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 1 April 2019

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Clarke, Yvette D. [D-NY-9] · D · Sponsor
• Rep. Upton, Fred [R-MI-6] · R · Sponsor
• Rep. Rush, Bobby L. [D-IL-1] · D · Cosponsor
• Rep. Raskin, Jamie [D-MD-8] · D · Cosponsor
• Rep. Peters, Scott H. [D-CA-50] · D · Cosponsor
• Rep. Moulton, Seth [D-MA-6] · D · Cosponsor
• Rep. Pocan, Mark [D-WI-2] · D · Cosponsor
• Rep. Engel, Eliot L. [D-NY-16] · D · Cosponsor
• Rep. Krishnamoorthi, Raja [D-IL-8] · D · Cosponsor
• Rep. Gonzalez, Vicente [D-TX-34] · D · Cosponsor
• Rep. Bonamici, Suzanne [D-OR-1] · D · Cosponsor
• Rep. Meadows, Mark [R-NC-11] · R · Cosponsor
• Rep. Johnson, Bill [R-OH-6] · R · Cosponsor
• Rep. Himes, James A. [D-CT-4] · D · Cosponsor
• Rep. Morelle, Joseph D. [D-NY-25] · D · Cosponsor
• Rep. Butterfield, G. K. [D-NC-1] · D · Cosponsor
• Sen. Blunt Rochester, Lisa [D-DE] · D · Cosponsor
• Rep. Tonko, Paul [D-NY-20] · D · Cosponsor
• Rep. DeGette, Diana [D-CO-1] · D · Cosponsor
• Rep. Veasey, Marc A. [D-TX-33] · D · Cosponsor
• · hsif00 · Standing
• · hswm00 · Standing

Related records

• related to ← Allergy Testing Access Act of 2019